Sprycel (dasatinib)
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Sprycel (dasatinib), covering 2009-03-03 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia [Phase 2]